Jump Financial, LLC Exact Sciences Corp Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.43 - $70.83 $2.35 Million - $3.93 Million	-55,502 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $2.29 Million - $4.12 Million	55,502 New	55,502 $2.34 Million
Q3 2023 Oct 21, 2024	SELL	$65.94 - $99.04 $1.65 Million - $2.48 Million	-25,054 Reduced 45.14%	30,448 $2.08 Million
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $2.01 Million - $3.02 Million	30,448 New	30,448 $2.08 Million
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $3.76 Million - $6.58 Million	-123,818 Reduced 94.54%	7,151 $354,000
Q3 2022 Nov 07, 2022	BUY	$31.97 - $49.37 $4.19 Million - $6.47 Million	130,969 New	130,969 $4.26 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $1.16 Million - $1.55 Million	-9,970 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $125,209 - $178,644	1,257 Added 14.43%	9,970 $1.32 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $635,351 - $888,813	8,713 New	8,713 $889,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.